NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CureMetrix

CureMetrix

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://curemetrix.com/

Last Round

Series C

Sep 17, 2024

Total Funding Raised

$30M

Company Overview

CureMetrix is a healthcare technology company that develops artificial intelligence-based software for medical image analysis, primarily focused on mammography and breast health.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AImammography AIcomputer-aided detectionCADbreast cancer detectionradiology workflowbreast arterial calcificationBACbreast density classificationradiology AIclinical decision supportFDA-cleared AImedical softwareAI triageradiology tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureMetrix Comps

Public and private peers based on sector, stage, and business model.

CureMetrix comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CureMetrix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 17, 2024
SeedMay 13, 2015
AcceleratorAug 1, 2014

Key People

Founding team and executive leadership

Navid Alipour

Chief Executive Officer, Co-Founder Board Member

Founding Team

Tom Saftig

CFO

Executive Team

CureMetrix Investors

Notable investors and investment history

CureMetrix investors
InvestorRounds
Analytics VenturesSeed, Accelerator
EvoNexusAccelerator, Seed
XB VenturesSeries C
Keshif VenturesSeed, Accelerator
UnitleaderSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 60% MoM.

  • Dec 14, 2024

    Monthly visitors grew 60% MoM.

CureMetrix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CureMetrix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CureMetrix's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range45
Year Founded2014
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.